8-K filed January 2, 2026, 6:59 PM ET ticker CDT CIK 0001896212

other material confidence high sentiment neutral materiality 0.40

CDT enters consulting pacts with Thesprogen and NJS; issues 213,288 shares for $305k in services

CDT Equity Inc.

Thesprogen will evaluate AZD1656 pre-clinical data and optimize development strategies; 6-month term, $155k fee paid in 108,392 shares.
NJS to identify out-licensing partners for solid-form patent portfolio; $150k retainer in 104,896 shares plus 8% commission on transactions.
Shares issued in unregistered transaction under Regulation D; no registration rights granted.
Press release highlights NJS engagement to accelerate licensing and royalty-based deals for solid-form assets.

item 1.01 item 3.02 item 7.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001493152-26-000143
form_type: 8-K
ticker: CDT
cik: 0001896212
company_name: CDT Equity Inc.
filed_at: 2026-01-02T23:59:59+00:00
discovered_at: 2026-05-14T18:02:36.704764+00:00
generated_at: 2026-05-16T11:51:02.535706+00:00
sec_items: ["1.01", "3.02", "7.01", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001493152-26-000143
json_url: https://secwatch.observer/filing/0001493152-26-000143.json
markdown_url: https://secwatch.observer/filing/0001493152-26-000143.md
text_url: https://secwatch.observer/filing/0001493152-26-000143.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1896212/000149315226000143/0001493152-26-000143-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1896212/000149315226000143/form8-k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source-grounded claims

65c7ef4361a483c545ae93fb9f368e593635e29b

CDT Equity Inc. entered into Thesprogen Agreement with Thesprogen, PC valued at $155,000 of consideration (effective 2025-12-28).

On December 28, 2025, CDT Equity, Inc. (the “Company” or “CDT”) and Thesprogen, PC (“Thesprogen”) entered into a Consulting Agreement (the “Thesprogen Agreement”)

SEC 8-K Item 1.01/1.02 confidence 0.9 SEC evidence

7967154b808bcc100b3e113e029d19154f2a3b80

CDT Equity Inc. entered into NJS Agreement with NJS Foresight Bio-Advisory, LLC valued at one-time fixed retainer of $150,000 (effective 2025-12-29).

On December 29, 2025 (the “Effective Date”) the Company and NJS Foresight Bio-Advisory, LLC (“NJS”) entered into a Consulting Agreement (the “NJS Agreement,” together with the Thesprogen Agreement, the “Agreements”)

SEC 8-K Item 1.01/1.02 confidence 0.9 SEC evidence

Comparable filings

GOVX

GeoVax raises ~$595k via warrant inducement; issues new warrants for 1M shares at $1.65

GeoVax Labs, Inc. May 7, 2026, 7:59 PM ET other_material Items 1.01, 3.02, 9.01

same fact type: material_agreement same SEC item: 1.01, 3.02, 9.01 same event type: other_material similar materiality

This filing

On December 28, 2025, CDT Equity, Inc. (the “Company” or “CDT”) and Thesprogen, PC (“Thesprogen”) entered into a Consulting Agreement (the “Thesprogen Agreement”)

Comparable filing

On May 7, 2026, GeoVax Labs Inc. (the “Company”), entered into common stock warrant exercise inducement offer letters (the “Inducement Letters”) with holders (the “Holders”) of existing warrants to purchase shares of the Company’s common stock

Filing page SEC filing

BRANDYWINE OPERATING PARTNERSHIP, L.P.

Brandywine extends revolver maturity to Dec 2026; shareholders OK 5M share increase for LTIP

BRANDYWINE OPERATING PARTNERSHIP, L.P. June 1, 2026, 4:30 PM ET other_material Items 1.01, 2.03, 5.02, 5.07, 9.01

same fact type: material_agreement same SEC item: 1.01, 9.01 same event type: other_material similar materiality

This filing

On December 28, 2025, CDT Equity, Inc. (the “Company” or “CDT”) and Thesprogen, PC (“Thesprogen”) entered into a Consulting Agreement (the “Thesprogen Agreement”)

Comparable filing

extended the maturity date of the Borrowers’ revolving credit facility

Filing page SEC filing

BMO 2026-5C14 Mortgage Trust

BMO 2026-5C14 transfers Compass Storage Whole Loan servicing to Benchmark 2026-V22

BMO 2026-5C14 Mortgage Trust June 1, 2026, 2:53 PM ET other_material Items 1.01, 9.01

same fact type: material_agreement same SEC item: 1.01, 9.01 same event type: other_material similar materiality

This filing

On December 28, 2025, CDT Equity, Inc. (the “Company” or “CDT”) and Thesprogen, PC (“Thesprogen”) entered into a Consulting Agreement (the “Thesprogen Agreement”)

Comparable filing

On March 25, 2026 (the “ Closing Date ”), BMO 2026-5C14 Mortgage Trust (the “ Issuing Entity ”) issued the BMO 2026-5C14 Mortgage Trust, Commercial Mortgage Pass-Through Certificates, Series 2026-5C14, pursuant to a Pooling and Servicing Agreement, dated as of March 1, 2026 (the “ Pooling and Servicing Agreement ”), between BMO Commercial Mortgage Securities LLC, as depositor, Midland Loan Services, a Division of PNC Bank, National Association, as master servicer, CWCapital Asset Management LLC, as special servicer, Pentalpha Surveillance LLC, as operating advisor and as asset representations reviewer, and Computershare Trust Company, National Association, as certificate administrator and as trustee.

Filing page SEC filing

SNYR

Synergy CHC enters up to $36M equity purchase agreement with Hudson Global Ventures

Synergy CHC Corp. May 11, 2026, 7:59 PM ET other_material Items 1.01, 9.01

same fact type: material_agreement same SEC item: 1.01, 9.01 same event type: other_material similar materiality

This filing

On December 28, 2025, CDT Equity, Inc. (the “Company” or “CDT”) and Thesprogen, PC (“Thesprogen”) entered into a Consulting Agreement (the “Thesprogen Agreement”)

Comparable filing

On May 8, 2026, Synergy CHC Corp. (the “Company”) entered into an equity purchase agreement (the “Purchase Agreement”) with Hudson Global Ventures, LLC (the “Investor”), pursuant to which the Company has the right, but not the obligation, to direct the Investor to purchase up to $36,000,000 of the Company’s common stock

Filing page SEC filing

AAT

AAT board raises Rady Trust ownership cap to 21.9%, lowers general limit to 6.775%

American Assets Trust, Inc. May 11, 2026, 7:59 PM ET other_material Items 1.01, 3.03, 9.01

same fact type: material_agreement same SEC item: 1.01, 9.01 same event type: other_material similar materiality

This filing

On December 28, 2025, CDT Equity, Inc. (the “Company” or “CDT”) and Thesprogen, PC (“Thesprogen”) entered into a Consulting Agreement (the “Thesprogen Agreement”)

Comparable filing

On May 11, 2026, American Assets Trust, Inc. (the "Company") entered into a Voting Support Agreement (the "Voting Agreement") with the Ernest Rady Trust U/D/T March 10, 1983 (the "Rady Trust"), the Evelyn Shirley Rady Trust U/D/T March 10, 1983, and American Assets, Inc. (collectively, the "Stockholder").

Filing page SEC filing

21Shares Polkadot ETF

21Shares Polkadot ETF enters Figment staking agreement; 26.5% of rewards to service providers

21Shares Polkadot ETF May 8, 2026, 7:59 PM ET other_material Items 1.01, 9.01

same fact type: material_agreement same SEC item: 1.01, 9.01 same event type: other_material similar materiality

This filing

On December 28, 2025, CDT Equity, Inc. (the “Company” or “CDT”) and Thesprogen, PC (“Thesprogen”) entered into a Consulting Agreement (the “Thesprogen Agreement”)

Comparable filing

On May 4, 2026, 21Shares Polkadot ETF (the “Trust”) entered into a staking services agreement with Figment Inc., an Ontario corporation (“Figment” and such agreement, the “Figment Agreement”),

Filing page SEC filing

PBHC

Pathfinder Bancorp and Castle Creek Amend Registration Rights Agreement, Extending Filing Deadline to May 8, 2027

Pathfinder Bancorp, Inc. May 7, 2026, 7:59 PM ET other_material Items 1.01, 9.01

same fact type: material_agreement same SEC item: 1.01, 9.01 same event type: other_material similar materiality

This filing

On December 28, 2025, CDT Equity, Inc. (the “Company” or “CDT”) and Thesprogen, PC (“Thesprogen”) entered into a Consulting Agreement (the “Thesprogen Agreement”)

Comparable filing

On May 4, 2026, the Company and Castle Creek agreed to amend the Registration Rights Agreement to allow the Company to file a resale registration statement by no later than May 8, 2027 to register the resale of the securities.

Filing page SEC filing

ENB

Enbridge shareholders approve directors, auditor, say-on-pay, and rights plan at AGM

ENBRIDGE INC May 7, 2026, 7:59 PM ET other_material Items 1.01, 3.03, 5.07, 9.01

same fact type: material_agreement same SEC item: 1.01, 9.01 same event type: other_material similar materiality

This filing

On December 28, 2025, CDT Equity, Inc. (the “Company” or “CDT”) and Thesprogen, PC (“Thesprogen”) entered into a Consulting Agreement (the “Thesprogen Agreement”)

Comparable filing

the holders of common shares of Enbridge Inc. (the “Corporation”) voted to amend, reconfirm and approve the Corporation’s shareholder rights plan (the “Rights Plan”) under the terms of an agreement between the Corporation and Computershare Trust Company of Canada (“Computershare”), as rights agent.

Filing page SEC filing

Source: SEC EDGAR

accession 0001493152-26-000143

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.